The PE Ratio as of November 2024 (TTM) for Achieve Life Sciences, Inc. (ACHV) is -4.39

According to Achieve Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -4.39. This represents a change of 6.81% compared to the average of -4.11 of the last 4 quarters.

Achieve Life Sciences, Inc. (ACHV) Historical PE Ratio (quarterly & annually)

How has ACHV PE Ratio performed in the past?

The mean historical PE Ratio of Achieve Life Sciences, Inc. over the last ten years is -1.22. The current -4.39 PE Ratio has changed 35.88% with respect to the historical average. Over the past ten years (40 quarters), ACHV's PE Ratio was at its highest in in the December 2019 quarter at -0.45. The PE Ratio was at its lowest in in the December 2015 quarter at -5.24.

Achieve Life Sciences, Inc. (ACHV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Achieve Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Achieve Life Sciences, Inc. (ACHV) Average PE Ratio

How has ACHV PE Ratio performed in the past?

The current PE Ratio of Achieve Life Sciences, Inc. (ACHV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Achieve Life Sciences, Inc. (ACHV) PE Ratio vs. Peers

How is ACHV’s PE Ratio compared to its peers?

Achieve Life Sciences, Inc.’s PE Ratio is greater than VectivBio Holding AG (-7.94), greater than Icosavax, Inc. (-8.27), greater than Apellis Pharmaceuticals, Inc. (-10.63), less than iTeos Therapeutics, Inc. (-3.29), greater than TScan Therapeutics, Inc. (-5.52), greater than Day One Biopharmaceuticals, Inc. (-17.12), less than Acumen Pharmaceuticals, Inc. (-2.73), less than X4 Pharmaceuticals, Inc. (6.04), less than Inozyme Pharma, Inc. (-3.09), less than Immix Biopharma, Inc. (-2.39), less than CNS Pharmaceuticals, Inc. (-0.00), less than Hepion Pharmaceuticals, Inc. (-0.13), less than Freeline Therapeutics Holdings plc (-0.57), less than AVROBIO, Inc. (2.07), less than NextCure, Inc. (-0.60), less than CytomX Therapeutics, Inc. (7.73), less than Neoleukin Therapeutics, Inc. (-0.98), less than Spero Therapeutics, Inc. (3.99), less than Assembly Biosciences, Inc. (-2.10), less than Bolt Biotherapeutics, Inc. (-0.38), less than Coherus BioSciences, Inc. (-2.62), greater than Gracell Biotechnologies Inc. (-12.30),

Build a custom stock screener for Achieve Life Sciences, Inc. (ACHV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Achieve Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Achieve Life Sciences, Inc. (ACHV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Achieve Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.